Federal saving from lowering of drug prices is unclear

While The White House hailed what it described as a "historic agreement to lower drugs costs" for older Americans, it was not immediately clear how much the government would reap in savings that could be used to pay for coverage of the uninsured. As part of the agreement, pharmaceutical companies promised to help narrow a gap in Medicare coverage of prescription drugs that is known as the doughnut hole.